San Diego-based Organovo Holdings Inc., a designer and manufacturer of three-dimensional human tissues for medical research, is working with researchers at Autodesk Inc. to create the first 3-D design software for bioprinting, the company announced.
According to a release, Autodesk, a specialist in cloud-based design and engineering software, regularly collaborates with researchers at universities around the world. The private collaboration announced Tuesday will produce a software that will be used to control Organovo's NovoGen MMX bioprinter.
"Autodesk is an excellent partner for Organovo in developing new software for 3-D bioprinters," Keith Murphy, chairman and CEO at Organovo, said. "This relationship will lead to advances in bioprinting, including both greater flexibility and throughput internally, and the potential long-term ability for customers to design their own 3-D tissues for production by Organovo."
Jeff Kowalski, senior vice president and chief technology officer at Autodesk, called it a blend of engineering, biology and 3-D printing, making it a natural fit for Autodesk.
Organovo's 3-D bioprinting technology is used to create living human tissues that are three-dimensional, architecturally correct, and made entirely of living human cells. The resulting structures can function like native human tissues, and represent an opportunity for advancement in medical research, drug discovery and development, and in the future, surgical therapies and transplantation.
6275 Nancy Ridge Dr. Ste., 110
San Diego, CA 92121